Arstasis Inc.
Industry
- Medical Devices
See more in Biomedtracker
Latest on Arstasis Inc.
Scrip
IN VITRO DIAGNOSTICS Agendia BV Agendia raises $65mm through late-stage round A year after withdrawing its IPO filing, molecular diagnostics firm Agendia BV has raised $65mm in what appears to
Medtech Insight
Although the vascular access repair products market continues to be dominated by two multinationals, St. Jude Medical Inc. and Abbott Vascular / Abbott Laboratories Inc. , their share will be
In Vivo
Device Transactions Although medical device companies had a strong opening in 2012 — they brought in $1.1 billion in Q1— the second quarter saw a dip in the money raised. While it is certainly a respe